ARS Pharmaceuticals, Inc
Ownership
Ownership Structure
Who owns ARS Pharmaceuticals, Inc (SPRY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.3% of the shares are freely tradable; institutional investors hold 95.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 10.92 | 10,860,977 | +0.0 | 03/31/2026 |
| Orbimed Advisors LLC | 8.33 | 8,288,510 | +0.0 | 03/31/2026 |
| Rubric Capital Management LP | 8.04 | 8,000,000 | +29.0 | 03/31/2026 |
| Deerfield Management Co | 7.55 | 7,503,812 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.04 | 5,012,254 | -1.4 | 03/31/2026 |
| Tyro Capital Management LLC | 4.48 | 4,459,337 | +50.2 | 06/30/2026 |
| Aberdeen Group PLC | 4.19 | 4,170,629 | +1.4 | 06/30/2026 |
| SR ONE CAPITAL MANAGEMENT, LP | 4.04 | 4,012,903 | +0.0 | 06/30/2026 |
| State Street Corp | 3.67 | 3,644,966 | +13.1 | 03/31/2026 |
| Franklin Templeton Inc | 3.30 | 3,278,549 | +28.9 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.